Psychedelic drug developer Compass Pathways is preparing to talk to the FDA about filing its psilocybin therapy COMP360 for approval in treatment-resistant depression (TRD), after reporting positive ...

Compass Pathways may be the first to benefit from an accelerated approval process.

Compass Minerals (CMP) outlook: structural salt advantages, SHACOG impact minimal, pricing tailwinds post-Cargill. Read here ...

Midwest Real Estate Data is expanding its MLS nationwide, giving any licensed real estate agent access to its platform and PLN.

The Chicago MLS, which runs a private listing network, is expanding nationwide to give agents “more choices.” It will receive ...